磁共振T2mapping和IDEAL成像技术对腰椎间盘退变的定量评价

注册号:

Registration number:

ChiCTR-RDC-17012834 

最近更新日期:

Date of Last Refreshed on:

2017-09-29 11:56:23 

注册时间:

Date of Registration:

2017-09-29 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

磁共振T2mapping和IDEAL成像技术对腰椎间盘退变的定量评价

Public title:

Quantitative assessment of intervertebral disc degeneration using T2 mapping and IDEAL

注册题目简写:

English Acronym:

研究课题的正式科学名称:

磁共振T2mapping和IDEAL成像技术对腰椎间盘退变的定量评价

Scientific title:

Quantitative assessment of intervertebral disc degeneration using T2 mapping and IDEAL

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陈晓飞 

研究负责人:

周晟 

Applicant:

Xiao-fei Chen 

Study leader:

Sheng Zhou 

申请注册联系人电话:

Applicant telephone:

+86 13919044908

研究负责人电话:

Study leader's
telephone:

+86 15002591656

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

cxf750915@sina.com

研究负责人电子邮件:

Study leader's E-mail:

lzzs@sina.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

甘肃省兰州市七里河区瓜州路418号

研究负责人通讯地址:

甘肃省兰州市七里河区瓜州路418号

Applicant address:

418 Guazhou Road, Qilihe District, Lanzhou, China

Study leader's address:

418 Guazhou Road, Qilihe District, Lanzhou, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

甘肃省中医院

Applicant's institution:

Gansu provincial hospital of TCM

研究负责人所在单位:

甘肃省中医院

Affiliation of the Leader:

Gansu provincial hospital of TCM

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2017-055-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

甘肃省中医院伦理委员会

Name of the ethic committee:

The ethics committee of Gansu provincial hospital of TCM

伦理委员会批准日期:

Date of approved by ethic committee:

2017-09-14 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

甘肃省中医院

Primary sponsor:

Gansu provincial hospital of TCM

研究实施负责(组长)单位地址:

甘肃省兰州市七里河区瓜州路418号

Primary sponsor's address:

418 Guazhou Road, Qilihe District,Lanzhou, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

甘肃省

市(区县):

Country:

China

Province:

Gansu

City:

单位(医院):

甘肃省科学技术厅

具体地址:

兰州市庆阳路166号

Institution
hospital:

Gansu provincial Sci.and Tech. Department

Address:

166 Qingyang Road, Lanzhou, China

经费或物资来源:

甘肃省中医院、甘肃省科技厅

Source(s) of funding:

Funding by Gansu provincial hospital of TCM and Gansu provincial Sci. and Tech. Department

研究疾病:

椎间盘退变  

Target disease:

intervertebral disc degeneration

研究疾病代码:

Target disease code:

研究类型:

病因学/相关因素研究

Study type:

Cause/Relative factors study

研究所处阶段:

诊断试验新技术临床试验 

Study phase:

Diagnostic New Technique Clincal Study

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

基于磁共振QMRI技术,在3.0T磁共振成像系统平台上,采集下腰痛患者的T2mapping成像、IDEAL加权成像数据。分析IVDD的T2值、FSF、WSF与Pfirrmann分级及下腰痛临床评分的相关性。对比研究磁共振T2mapping成像、IDEAL成像的对IVDD定量的优势,探讨QMRI对IVDD早期定量诊断的应用价值。  

Objectives of Study:

Based on QMRI, T2mapping imaging and IDEAL weighted imaging data of patients with lower back pain were acquired on the 3.0T MRI. T2 value of IVDD, FSF, WSF and Pfirrmann grading and lower back pain was analyzed. To compare the quantitative advantages of T2mapping imaging and IDEAL imaging to IVDD. Explore the application value of QMRI in early quantitative diagnosis of IVDD.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

妊娠,哺乳期妇女;重患者或存在心、肝、肾功能衰竭;精神障碍、肢体残疾、智力障碍;不愿受试者。

Exclusion criteria:

Pregnancy, lactating women; Patients with heart, liver, renal multiple system organ failure; Mental disorders, physical disability, mental retardation; Claustrophobia;Unwilling subjects.

研究实施时间:

Study execute time:

From 2017-10-01 00:00:00 To 2019-09-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2017-10-01 00:00:00 To 2019-09-01 00:00:00

干预措施:

Interventions:

组别:

Pfirrmann分级I

样本量:

25

Group:

IVDD grade I

Sample size:

干预措施:

腰椎MRI扫描

干预措施代码:

Intervention:

lumbar spine MRI scanning

Intervention code:

组别:

Pfirrmann分级II

样本量:

25

Group:

IVDD grade II

Sample size:

干预措施:

腰椎MRI扫描

干预措施代码:

Intervention:

lumbar spine MRI scanning

Intervention code:

组别:

Pfirrmann分级III

样本量:

25

Group:

IVDD gradeIII

Sample size:

干预措施:

腰椎MRI扫描

干预措施代码:

Intervention:

lumbar spine MRI scanning

Intervention code:

组别:

Pfirrmann分级IV

样本量:

25

Group:

IVDD gradeIV

Sample size:

干预措施:

腰椎MRI扫描

干预措施代码:

Intervention:

lumbar spine MRI scanning

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

甘肃省 

市(区县):

 

Country:

China

Province:

Gansu

City:

单位(医院):

甘肃省中医院 

单位级别:

三级甲等 

Institution
hospital:

Gansu provincial hospital of TCM

Level of the institution:

Tertiary A hospital

测量指标:

Outcomes:

指标中文名:

T2值

指标类型:

主要指标

Outcome:

T2 value

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脂肪信号分数

指标类型:

主要指标

Outcome:

fat signal fraction, FSF

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

水信号分数

指标类型:

主要指标

Outcome:

Water signal fraction, WSF

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

磁共振数据

组织:

Sample Name:

MRI data

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 50 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由三名诊断医师根据Pfirrmann分级标准,对椎间盘进行分级分组,不做随机处理。

Randomization Procedure (please state who generates the random number sequence and by what method):

According to the classification standard of Pfirrmann, the three diagnostic doctors classified the intervertebral discs and did not do random processing.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验完成后6月内公开

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Within six months after the trial complete

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

注册人:

Name of Registration:

 2017-09-29 11:56:23